September is Blood Cancer Awareness Month. All month, HealthTree is sharing important educational information about blood cancers.
World Leukemia Day is an annual global event that is celebrated every year on September 4. This is a time to educate the public on leukemia and encourage early diagnosis. Leukemia is the 13th most common cancer globally, and it affects more than 1,000 people every day. Raising awareness of this disease can help patients get diagnosed and have better outcomes.
Here are some of the latest articles and updates about leukemia.
Childhood Leukemia Symptoms: Early Signs Parents Should Know
Leukemia, a type of blood cancer, is the most common childhood cancer. The early signs and symptoms can be the same as many common illnesses. It is important for parents and caregivers to know what to look for. This can help you recognize changes that may need further evaluation.
Read now: the early signs of childhood leukemia
Inotuzumab Ozogamicin (Besponsa) Therapy Helps People With Relapsed Or Refractory B-Cell ALL Reach MRD Negativity
A recent study found that inotuzumab ozogamicin (InO) helped patients with acute lymphoblastic leukemia (ALL) reach minimal residual disease (MRD) negativity. The patients had relapsed or refractory B-cell ALL that was in remission but still had some remaining cancer cells.
InO, also known as Besponsa (Pfizer), is an FDA approved antibody drug conjugate (ADC) used to treat relapsed or refractory B-cell ALL in adults. ADCs work by delivering chemotherapy directly to cancer cells. InO was approved for use in people with ALL in 2017. This research looked at previously treated B-cell ALL that was in complete remission with positive MRD.
CDC Alert: Patients Treated With Immunotherapy At Higher Risk For Complications From Mosquito-Borne Virus
The U.S. Centers for Disease Control and Prevention (CDC) are sharing an important warning for people who take B-cell depleting or B-cell modulation medications, especially anti-CD20 monoclonal antibodies. These treatments lower specific immune cells and may increase the risk of complications from viruses spread by mosquito and tick bites. Knowing how to protect yourself and what signs to watch for can help you stay safe while managing your care.
Adult AML Survivors Have A Higher Risk Of Second Cancers
As treatments for acute myeloid leukemia (AML) continue to improve, more people are living longer after their diagnosis. Research is ongoing to understand how AML and its treatment affect survivors. One common risk is secondary cancer.
New research presented at the 2026 American Society of Clinical Oncology Annual Meeting found that adults who survive AML have a higher risk of developing certain second primary cancers, particularly blood cancers. The findings may help healthcare teams better tailor cancer screening and long-term follow-up care for AML survivors.
Read now: Adult AML Survivors & Second Cancers
World Leukemia Day is an important opportunity to raise awareness, share the latest research, and remind patients about an early diagnosis and ongoing care. Recent advances in leukemia treatment are helping to improve outcomes for people living with this disease. Research will continue to highlight the importance of disease monitoring, infection prevention, and the need for screening for survivors. By staying informed and supporting research, we can work together to improve the lives of people affected by leukemia.
The latest research, to your inbox.
Never miss another research update. Subscribe to HealthTree's informational newsletter to stay up-to-date on the latest leukemia research.
